Literature DB >> 6756926

Prenatal diagnosis of cystic fibrosis: false negative result with the 4-methylumbelliferyl-p-guanidinobenzoate assay for proteases in amniotic fluid.

J R Green, M J Lentze, E Rossi, D Sidiropoulos, G Schubiger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6756926     DOI： 10.1007/bf00442076

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  16 in total

1.  Arginine esterase in amniotic fluid: possible marker for cystic fibrosis.

Authors:  L G Dann; K Blau
Journal:  Lancet       Date:  1979-10-27       Impact factor: 79.321

2.  Prenatal detection of cystic fibrosis.

Authors:  H L Nadler; P Rembelski; K H Mesirow
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

3.  Methylumbelliferyl-guanidinobenzoate reactive proteases in amniotic fluid: possible marker for cystic fibrosis.

Authors:  M M Walsh; H L Nadler
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

4.  Methylumbelliferyl-guanidinobenzoate reactive proteases and prenatal diagnosis of cystic fibrosis.

Authors:  D J Brock; C Hayward
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

5.  Intrauterine detection of cystic fibrosis.

Authors:  H L Nadler; M M Walsh
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

6.  Methylumbelliferylguanidinobenzoate-reactive proteases in human amniotic fluid: Promising marker for the intrauterine detection of cystic fibrosis.

Authors:  M M Walsh; H L Nadler
Journal:  Am J Obstet Gynecol       Date:  1980-08-15       Impact factor: 8.661

7.  Protease deficiency in plasma of patients with cystic fibrosis. Reduced reaction of 4-methylumbelliferylguanidinobenzoate with plasma of patients with cystic fibrosis.

Authors:  M Walsh-Platt; G J Rao; H L Nadler
Journal:  Enzyme       Date:  1979

8.  Reaction of 4-methylumbelliferylguanidinobenzoate with cultivated human skin fibroblasts derived from patients with cystic fibrosis.

Authors:  M W Platt; G J Rao; H L Nadler
Journal:  Pediatr Res       Date:  1978-08       Impact factor: 3.756

9.  Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in plasma of patients with cystic fibrosis.

Authors:  G J Rao; M W Platt; H L Nadler
Journal:  Enzyme       Date:  1978

10.  Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in human amniotic fluid.

Authors:  M M Walsh; G J Rao; H L Nadler
Journal:  Pediatr Res       Date:  1980-04       Impact factor: 3.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.